{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:44:12Z","timestamp":1780112652841,"version":"3.54.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jemermed.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:04:21Z","timestamp":1769875461000},"page":"57-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tirzepatide-Associated Euglycemic Diabetic Ketoacidosis in the Absence of Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report"],"prefix":"10.1016","volume":"83","author":[{"given":"Christina","family":"Campana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Ceraolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2026.01.002_bib0001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajem.2021.02.015","article-title":"Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management","volume":"44","author":"Long","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2019.03.014","article-title":"Euglycemic diabetic ketoacidosis","volume":"63","author":"Barski","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic diabetic ketoacidosis: a review","volume":"13","author":"Modi","year":"2017","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0004","article-title":"A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide","volume":"16","author":"Huang","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034027","article-title":"Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes","volume":"102","author":"Alduraibi","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0006","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.numecd.2021.10.003","article-title":"The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system","volume":"32","author":"Yang","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0007","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/ph18020214","article-title":"Diabetic ketoacidosis and the use of new hypoglycemic groups: real-world evidence utilizing the Food and Drug Administration Adverse event Reporting System","volume":"18","author":"Thaibah","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0008","article-title":"GLP-1 receptor agonist-induced diabetic ketoacidosis: a case report","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40265-023-01992-4","article-title":"Tirzepatide: a review in type 2 diabetes","volume":"84","author":"France","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jama.2022.0078","article-title":"Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial","volume":"327","author":"Dahl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0011","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 Diabetes, 2022. A consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care."},{"key":"10.1016\/j.jemermed.2026.01.002_bib0012","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s11606-022-07993-5","article-title":"Euglycemic diabetic ketoacidosis caused by alcoholic pancreatitis and starvation ketosis","volume":"38","author":"Han","year":"2023","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0013","article-title":"Euglycemic ketoacidosis from semaglutide in a patient without diabetes","volume":"2","author":"Sood","year":"2024","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0014","article-title":"Euglycemic ketoacidosis in a non-diabetic patient after tirzepatide use: a cautionary tale","volume":"17","author":"Singh","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jemermed.2026.01.002_bib0016","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.2337\/dc25-S006","article-title":"Glycemic Goals and hypoglycemia: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646792600003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646792600003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:24:14Z","timestamp":1773923054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073646792600003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":15,"alternative-id":["S073646792600003X"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2026.01.002","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide-Associated Euglycemic Diabetic Ketoacidosis in the Absence of Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}